Is the Galleri multi-cancer blood test worth it? A doctor's analyses of real-world performance data. Learn why no major ...

Telehealth company Hims & Hers has added Grail’s blood cancer test Galleri to its offerings as the medtech has now sent off ...

Comprehensive biomarker testing is crucial for NSCLC treatment, yet disparities exist between academic and community settings ...

Cellares has joined forces with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford Innovative ...

Are you looking for migraine relief or a fast treatment to stop your headache, ease your mind and release all your stress?

In a significant move towards enhancing cancer detection and treatment, telehealth company Hims & Hers has announced the addition of Grail's Galleri multi-cancer blood test to its extensive digital ...

Cellares will establish a standardized platform manufacturing process on the Cell Shuttle and platform release assays on the Cell Q.

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a collaboration with the ...

With a shared purpose, we can realize the true promise of CRISPR and improve healthcare, providing hope to more patients with ...

Pentixafor PET/CT was well tolerated and demonstrated high specificity and moderate sensitivity for identifying unilateral ...

In 2025, Tamil Nadu recorded an estimated 1,00,097 new cancer cases in a single year, marking one of the highest recorded ...

Ochsner's national study with The GRAIL Galleri® test is finding at least one hidden cancer a week in unsuspecting people. “I fully believe that in five, maybe 10 years, it will be routine to go to ...